Description

[1-(4-Benzylpiperazin-1-Yl)-3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propan-2-Yl] Acetate is a high-purity, advanced pharmaceutical intermediate with a complex molecular structure designed for targeted synthesis. This compound matters for its role as a critical building block in the development of specialized active pharmaceutical ingredients (APIs), particularly those targeting neurological and cardiovascular pathways. Pharmaceutical R&D laboratories and fine chemical manufacturers need this material for the synthesis of novel therapeutic agents, process development, and scale-up activities.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel purine-based active pharmaceutical ingredients (APIs).
• Neurological Research: Used in the development of compounds targeting adenosine receptor modulation for potential treatments of CNS disorders.
• Cardiovascular Drug Development: Applied in research for creating molecules with potential vasodilatory or cardioprotective effects.
• Biochemical Tool Compound: Utilized in academic and industrial research to study enzyme inhibition and signal transduction pathways.
• Process Chemistry & Scale-Up: Employed in optimizing synthetic routes and scaling production from laboratory to pilot plant scale.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.

Basic Information

Product Name	[1-(4-Benzylpiperazin-1-Yl)-3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propan-2-Yl] Acetate
CAS No.	19977-15-2
Molecular Formula	C23H29N7O4
Molecular Weight	467.52 g/mol
Synonyms	1-(4-Benzylpiperazin-1-yl)-3-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-yl)propan-2-yl acetate; 7-[2-(Acetyloxy)-3-(4-benzyl-1-piperazinyl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 1,3-Dimethyl-7-[2-(acetyloxy)-3-(4-benzyl-1-piperazinyl)propyl]xanthine; Benzylpiperazine xanthine derivative acetate; BPPX acetate; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our [1-(4-Benzylpiperazin-1-Yl)-3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propan-2-Yl] Acetate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure compliance with stringent specifications for pharmaceutical intermediates. Certificates of Analysis (COA) detailing batch-specific results are available upon request, supporting your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.